Ni-Catalyzed C-H Functionalization in the Formation of a Complex Heterocycle: Synthesis of the Potent JAK2 Inhibitor BMS-911543.

BMS-911543 is a complex pyrrolopyridine investigated as a potential treatment for myeloproliferative disorders. The development of a short and efficient synthesis of this molecule is described. During the course of our studies, a Ni-mediated C-N bond formation was invented, which enabled the rapid construction of the highly substituted 2-aminopyridine core. The synthesis of this complex, nitrogen-rich heterocycle was accomplished in only eight steps starting from readily available materials.

[1]  Francisco Cervantes,et al.  JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. , 2012, The New England journal of medicine.

[2]  Bin Zheng,et al.  Development of a Robust Process for the Preparation of High-Quality Dicyclopropylamine Hydrochloride , 2014 .

[3]  H. H. Hodgson.  The Sandmeyer reaction. , 1947, Chemical reviews.

[4]  S. Buchwald,et al.  Highly selective room-temperature copper-catalyzed C-N coupling reactions. , 2006, Journal of the American Chemical Society.

[5]  Martin D. Eastgate,et al.  Regioselective synthesis of 1,4-disubstituted imidazoles. , 2012, Organic & biomolecular chemistry.

[6]  M. Scarsella,et al.  A rapid and convenient synthesis of tetrakis(triphenylphosphine)palladium(O) and -platinum(O) complexes by phase-transfer catalysis , 1991 .

[7]  The copper-catalyzed N-arylation of indoles. , 2002, Journal of the American Chemical Society.

[8]  G. Cuny,et al.  Synthesis of fused imidazoles, pyrroles, and indoles with a defined stereocenter α to nitrogen utilizing Mitsunobu alkylation followed by palladium-catalyzed cyclization. , 2011, The Journal of organic chemistry.

[9]  Z. Estrov,et al.  Chronic Myelogenous Leukemia: Biology and Therapy , 1999, Annals of Internal Medicine.

[10]  Qi Gao,et al.  The impact of palladium(II) reduction pathways on the structure and activity of palladium(0) catalysts. , 2013, Angewandte Chemie.

[11]  K. Yakushijin,et al.  Biomimetic synthesis of grossularines-1. , 2005, Angewandte Chemie.

[12]  K. Nicholas,et al.  Copper-Mediated Multiple C–H Functionalization of Aromatic N-Heterocycles: Bromoamination of Indoles and Pyrroles , 2012 .

[13]  S. Buchwald,et al.  An efficient copper-catalyzed coupling of aryl halides with imidazoles , 1999 .

[14]  A. Tefferi,et al.  Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia. , 2003, Leukemia research.

[15]  Y. Janin.  Preparation and chemistry of 3/5-halogenopyrazoles. , 2012, Chemical reviews.

[16]  G. Ege,et al.  Aminopyrazoles. IV . Pyrazol-3- and 5-amines from 2,3-dihaloalkanenitriles or 3-chloroacrylonitriles and hydrazines† , 1982 .

[17]  P. Wollan,et al.  Population‐based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted county study, 1976–1995 , 1999, American journal of hematology.

[18]  R. Rossi,et al.  Selective Palladium‐Catalyzed Suzuki–Miyaura Reactions of Polyhalogenated Heteroarenes , 2012 .

[19]  L. A. Carpino.  1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive , 1993 .

[20]  J. C. Sheehan,et al.  Notes- A Convenient Synthesis of Water-Soluble Carbodiimides. , 1961 .

[21]  Dirk Trauner,et al.  Biosynthetic and biomimetic electrocyclizations. , 2005, Chemical reviews.

[22]  P. Ross-Macdonald,et al.  Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2 , 2012, Leukemia.

[23]  W. Lewis,et al.  A New Route to α-Carbolines Based on 6π-Electrocyclization of Indole-3-alkenyl Oximes , 2013, Organic letters.

[24]  Kunihisa Yoshida,et al.  Anodic cyanation of 1-methylimidazoles. , 1987 .

[25]  Jesús A. Varela,et al.  Construction of pyridine rings by metal-mediated [2 + 2 + 2] cycloaddition. , 2003, Chemical reviews.

[26]  Martin D. Eastgate,et al.  The Development of Scalable and Efficient Methods for the Preparation of Dicyclopropylamine HCl Salt , 2011 .

[27]  F. Ullmann,et al.  Ueber Synthesen in der Biphenylreihe , 1901 .

[28]  David R. J. Hose,et al.  N,N′-Carbonyldiimidazole-Mediated Amide Coupling: Significant Rate Enhancement Achieved by Acid Catalysis with Imidazole·HCl , 2009 .

[29]  F. Ullmann,et al.  Ueber die Phenylirung von Phenolen , 1905 .

[30]  D. Gilliland,et al.  A role for JAK2 mutations in myeloproliferative diseases. , 2008, Annual review of medicine.

[31]  N. Hu,et al.  Ligand-Accelerated Catalysis of the Ullmann Condensation: Application to Hole Conducting Triarylamines , 1999 .

[32]  P. Campbell,et al.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.

[33]  S. Buchwald,et al.  A general and efficient copper catalyst for the amidation of aryl halides. , 2002, Journal of the American Chemical Society.

[34]  G. Ege,et al.  Aminopyrazoles. V. Structure assignment of 1H-pyrazol-3-and 5-amines by means of the 1H NMR δ(4-H)-values of their exo-N-toluenesulfonyl derivatives† , 1984 .

[35]  Iram Goldberg.  Ueber Phenylirungen bei Gegenwart von Kupfer als Katalysator , 1906 .

[36]  T. Ishikawa,et al.  2-Chloro-1,3-dimethylimidazolinium Chloride. 1. A Powerful Dehydrating Equivalent to DCC , 1999 .

[37]  H. Bregman,et al.  An unusual dehalogenation in the Suzuki coupling of 4-bromopyrrole-2-carboxylates , 2003 .

[38]  A. Pardanani.  JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials , 2008, Leukemia.

[39]  L. Melton,et al.  Trends in the incidence of polycythemia vera among olmsted county, Minnesota residents, 1935–1989 , 1994, American journal of hematology.

[40]  F. Ullmann.  Ueber eine neue Bildungsweise von Diphenylaminderivaten , 1903 .

[41]  De novo synthesis of substituted pyridines , 2004 .

[42]  J. Kochi.  The Mechanism of the Sandmeyer and Meerwein Reactions , 1957 .

[43]  M. Burke,et al.  A general solution for unstable boronic acids: slow-release cross-coupling from air-stable MIDA boronates. , 2009, Journal of the American Chemical Society.

[44]  J. Ho,et al.  Novel, potent non-covalent thrombin inhibitors incorporating p(3)-lactam scaffolds. , 2002, Bioorganic & medicinal chemistry letters.

[45]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.